InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P5
Near historical low
vs 3Y Ago
-1.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -64.99% |
| Q3 2025 | 27.64% |
| Q2 2025 | -15.22% |
| Q1 2025 | 4.12% |
| Q4 2024 | -25.76% |
| Q3 2024 | 12.68% |
| Q2 2024 | -11.85% |
| Q1 2024 | -5.36% |
| Q4 2023 | 0.00% |
| Q3 2023 | 100.00% |
| Q2 2023 | 71.47% |
| Q1 2023 | 27.35% |
| Q4 2022 | 37.55% |
| Q3 2022 | -55.46% |
| Q2 2022 | 13.91% |
| Q1 2022 | 34.33% |
| Q4 2021 | -86.33% |
| Q3 2021 | 12.51% |
| Q2 2021 | -5.51% |
| Q1 2021 | -62.01% |
| Q4 2020 | -23.68% |
| Q3 2020 | 24.86% |
| Q2 2020 | 5.57% |
| Q1 2020 | 12.07% |
| Q4 2019 | 12.95% |
| Q3 2019 | 15.16% |
| Q2 2019 | -28.51% |
| Q1 2019 | -23.05% |
| Q4 2018 | 4.21% |
| Q3 2018 | 1.35% |
| Q2 2018 | -35.91% |
| Q1 2018 | -35.86% |
| Q4 2017 | 15.95% |
| Q3 2017 | 1.77% |
| Q2 2017 | -60.32% |
| Q1 2017 | -32.88% |
| Q4 2016 | -118.69% |
| Q3 2016 | 19.25% |
| Q2 2016 | -35.00% |
| Q1 2016 | 47.45% |